Apple may add sensors to monitor blood sugar and alcohol levels in the upcoming Apple Watch

0

Your Apple Watch can tell you when you’ve had too much to drink or if your blood sugar is too high.

In recent SCC filings, British medical technology company Rockley Photonics named Apple as its ‘largest customer’, which could add its non-invasive sensors to the devices to measure a number of markers in the blood.

The sensors would hide with Apple’s device lying on the wrist and monitor blood pressure, blood sugar and alcohol levels.

The tech giant’s Apple Watch 6 is the first to read blood oxygen levels, but if the new technology makes it to the upcoming Watch, it could be a game changer for the more than 436 million people worldwide with diabetes.

Scroll down for video

Apple may soon add a blood glucose meter to an upcoming smartwatch, allowing diabetics to monitor their blood sugar levels non-invasively.  Sensors on the Apple Watch 6 (pictured) are already capable of measuring blood oxygen levels

Apple may soon add a blood glucose meter to an upcoming smartwatch, allowing diabetics to monitor their blood sugar non-invasively. Sensors on the Apple Watch 6 (pictured) are already capable of measuring blood oxygen levels

Rockley Photonics products monitor various health functions non-invasively with infrared, including body temperature, blood pressure and glucose, alcohol and oxygen levels in the blood.

“We’re focusing on the visible range and expanding it into the infrared range, getting much more accurate with laser technology compared to LEDs, which opens up a whole host of things,” said Andrew Rickman, Rockley CEO. Gazette Byte.

The company downsized a benchtop spectrometer to the size of a chip, making it “much further than watches today,” added Rickman, “much deeper, but not as deep as a blood draw.”

The mini spectrometer can detect glucose, urea, lactate and other chemical biomarkers in the blood that are indicative of disease.

Rockley Photonics, makers of chipsets that can detect blood sugar levels, blood pressure and other diagnostics, recently announced that technology giant Apple is its main customer

Rockley Photonics, makers of chipsets that can detect blood sugar levels, blood pressure and other diagnostics, recently announced that technology giant Apple is its main customer

More than 30 million Americans have type 2 diabetes, which requires regular blood glucose testing throughout the day.

While the condition most often develops in people over age 45, more and more children, teens, and young adults are developing it, according to the CDC.

Apple CEO Tim Cook personally took a test drive with a blood glucose meter in 2017, CNBC reported and there were rumors that such a monitor would come with the Apple 7, which would hit stores in September 2021.

But Rockley will ship its chipsets for health monitoring functions in the first half of 2022 at the earliest. Telegraph reported.

Rockley announced that Apple accounted for most of its 2019 and 2020 sales in SEC filings as it prepares for a public offering with an expected valuation of approximately $ 1.2 billion.

In February, the company announced that it had raised $ 65 million in funding to accelerate growth, bringing its total capital to more than $ 390 million.

“There is a tremendous need for technologies that enable effective digital health and wellness, driven by the attendant public health benefits,” said Rickman, the UK’s first internet billionaire.

“We are committed to our Tier-1 customers and our ability to expand their product offerings and the innovative data-driven business models that enable these products,” added Rickman.

According to him, Apple already has a patent on a blood pressure monitor Tom’s Guide.

The Apple Watch 6, released last fall, praised a number of health features, including a sensor that measures blood oxygen levels in just 15 seconds by measuring the color of the blood flowing through the wearer’s body.

Blood oxygen is most commonly used as a measure of fitness and heart health, indicating how well red blood cells transport oxygen around the body.

Critics have warned that relying on a smartwatch rather than actual medical care can saddle consumers with unnecessary medical bills and overload already frayed healthcare systems.

A 2020 study published in the Journal of the American Medical Informatics Association found that only about 10 percent of Apple Watch owners who were warned of an abnormal heart rate were diagnosed with a condition.

The watches can also cause people to ignore legitimate symptoms, such as dizziness or shortness of breath, because they have not received an official warning.

The heart monitor on the Apple Watch Series 4, released in 2018, allows users to perform an electrocardiogram to measure their heart’s electrical activity.

But consumers often don’t understand that the sensors are much less sophisticated than the EKG you get in a doctor’s office, which collects data from a dozen parts of your heart.

.